Cargando…
PKR-Mediated Phosphorylation of eIF2a and CHK1 Is Associated with Doxorubicin-Mediated Apoptosis in HCC1143 Triple-Negative Breast Cancer Cells
Triple-negative breast cancer is more aggressive than other types of breast cancer. Protein kinase R (PKR), which is activated by dsRNA, is known to play a role in doxorubicin-mediated apoptosis; however, its role in DNA damage-mediated apoptosis is not well understood. In this study, we investigate...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779813/ https://www.ncbi.nlm.nih.gov/pubmed/36555509 http://dx.doi.org/10.3390/ijms232415872 |
_version_ | 1784856701729505280 |
---|---|
author | Lee, Sol Jee, Ha-Yeon Lee, Yoon-Gyeong Shin, Jong-Il Jeon, Yong-Joon Kim, Ji-Beom Seo, Hye-eun Lee, Ji-Yeon Lee, Kyungho |
author_facet | Lee, Sol Jee, Ha-Yeon Lee, Yoon-Gyeong Shin, Jong-Il Jeon, Yong-Joon Kim, Ji-Beom Seo, Hye-eun Lee, Ji-Yeon Lee, Kyungho |
author_sort | Lee, Sol |
collection | PubMed |
description | Triple-negative breast cancer is more aggressive than other types of breast cancer. Protein kinase R (PKR), which is activated by dsRNA, is known to play a role in doxorubicin-mediated apoptosis; however, its role in DNA damage-mediated apoptosis is not well understood. In this study, we investigated the roles of PKR and its downstream players in doxorubicin-treated HCC1143 triple-negative breast cancer cells. Doxorubicin treatment induces DNA damage and apoptosis. Interestingly, doxorubicin treatment induced the phosphorylation of eukaryotic initiation factor 2 alpha (eIF2α) via PKR, whereas the inhibition of PKR with inhibitor C16 reduced eIF2α phosphorylation. Under these conditions, doxorubicin-mediated DNA fragmentation, cell death, and poly(ADP ribose) polymerase and caspase 7 levels were recovered. In addition, phosphorylation of checkpoint kinase 1 (CHK1), which is known to be involved in doxorubicin-mediated DNA damage, was increased by doxorubicin treatment, but blocked by PKR inhibition. Protein translation was downregulated by doxorubicin treatment and upregulated by blocking PKR phosphorylation. These results suggest that PKR activation induces apoptosis by increasing the phosphorylation of eIF2α and CHK1 and decreasing the global protein translation in doxorubicin-treated HCC1143 triple-negative breast cancer cells. |
format | Online Article Text |
id | pubmed-9779813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97798132022-12-23 PKR-Mediated Phosphorylation of eIF2a and CHK1 Is Associated with Doxorubicin-Mediated Apoptosis in HCC1143 Triple-Negative Breast Cancer Cells Lee, Sol Jee, Ha-Yeon Lee, Yoon-Gyeong Shin, Jong-Il Jeon, Yong-Joon Kim, Ji-Beom Seo, Hye-eun Lee, Ji-Yeon Lee, Kyungho Int J Mol Sci Article Triple-negative breast cancer is more aggressive than other types of breast cancer. Protein kinase R (PKR), which is activated by dsRNA, is known to play a role in doxorubicin-mediated apoptosis; however, its role in DNA damage-mediated apoptosis is not well understood. In this study, we investigated the roles of PKR and its downstream players in doxorubicin-treated HCC1143 triple-negative breast cancer cells. Doxorubicin treatment induces DNA damage and apoptosis. Interestingly, doxorubicin treatment induced the phosphorylation of eukaryotic initiation factor 2 alpha (eIF2α) via PKR, whereas the inhibition of PKR with inhibitor C16 reduced eIF2α phosphorylation. Under these conditions, doxorubicin-mediated DNA fragmentation, cell death, and poly(ADP ribose) polymerase and caspase 7 levels were recovered. In addition, phosphorylation of checkpoint kinase 1 (CHK1), which is known to be involved in doxorubicin-mediated DNA damage, was increased by doxorubicin treatment, but blocked by PKR inhibition. Protein translation was downregulated by doxorubicin treatment and upregulated by blocking PKR phosphorylation. These results suggest that PKR activation induces apoptosis by increasing the phosphorylation of eIF2α and CHK1 and decreasing the global protein translation in doxorubicin-treated HCC1143 triple-negative breast cancer cells. MDPI 2022-12-14 /pmc/articles/PMC9779813/ /pubmed/36555509 http://dx.doi.org/10.3390/ijms232415872 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lee, Sol Jee, Ha-Yeon Lee, Yoon-Gyeong Shin, Jong-Il Jeon, Yong-Joon Kim, Ji-Beom Seo, Hye-eun Lee, Ji-Yeon Lee, Kyungho PKR-Mediated Phosphorylation of eIF2a and CHK1 Is Associated with Doxorubicin-Mediated Apoptosis in HCC1143 Triple-Negative Breast Cancer Cells |
title | PKR-Mediated Phosphorylation of eIF2a and CHK1 Is Associated with Doxorubicin-Mediated Apoptosis in HCC1143 Triple-Negative Breast Cancer Cells |
title_full | PKR-Mediated Phosphorylation of eIF2a and CHK1 Is Associated with Doxorubicin-Mediated Apoptosis in HCC1143 Triple-Negative Breast Cancer Cells |
title_fullStr | PKR-Mediated Phosphorylation of eIF2a and CHK1 Is Associated with Doxorubicin-Mediated Apoptosis in HCC1143 Triple-Negative Breast Cancer Cells |
title_full_unstemmed | PKR-Mediated Phosphorylation of eIF2a and CHK1 Is Associated with Doxorubicin-Mediated Apoptosis in HCC1143 Triple-Negative Breast Cancer Cells |
title_short | PKR-Mediated Phosphorylation of eIF2a and CHK1 Is Associated with Doxorubicin-Mediated Apoptosis in HCC1143 Triple-Negative Breast Cancer Cells |
title_sort | pkr-mediated phosphorylation of eif2a and chk1 is associated with doxorubicin-mediated apoptosis in hcc1143 triple-negative breast cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779813/ https://www.ncbi.nlm.nih.gov/pubmed/36555509 http://dx.doi.org/10.3390/ijms232415872 |
work_keys_str_mv | AT leesol pkrmediatedphosphorylationofeif2aandchk1isassociatedwithdoxorubicinmediatedapoptosisinhcc1143triplenegativebreastcancercells AT jeehayeon pkrmediatedphosphorylationofeif2aandchk1isassociatedwithdoxorubicinmediatedapoptosisinhcc1143triplenegativebreastcancercells AT leeyoongyeong pkrmediatedphosphorylationofeif2aandchk1isassociatedwithdoxorubicinmediatedapoptosisinhcc1143triplenegativebreastcancercells AT shinjongil pkrmediatedphosphorylationofeif2aandchk1isassociatedwithdoxorubicinmediatedapoptosisinhcc1143triplenegativebreastcancercells AT jeonyongjoon pkrmediatedphosphorylationofeif2aandchk1isassociatedwithdoxorubicinmediatedapoptosisinhcc1143triplenegativebreastcancercells AT kimjibeom pkrmediatedphosphorylationofeif2aandchk1isassociatedwithdoxorubicinmediatedapoptosisinhcc1143triplenegativebreastcancercells AT seohyeeun pkrmediatedphosphorylationofeif2aandchk1isassociatedwithdoxorubicinmediatedapoptosisinhcc1143triplenegativebreastcancercells AT leejiyeon pkrmediatedphosphorylationofeif2aandchk1isassociatedwithdoxorubicinmediatedapoptosisinhcc1143triplenegativebreastcancercells AT leekyungho pkrmediatedphosphorylationofeif2aandchk1isassociatedwithdoxorubicinmediatedapoptosisinhcc1143triplenegativebreastcancercells |